Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Colorectal cancer AND IDH1, IDP, 3417, ENSG00000138413, IDH, PICD, O75874 AND Prognosis
19 results:

  • 1. Regorafenib and glioblastoma: a literature review of preclinical studies, molecular mechanisms and clinical effectiveness.
    Mongiardi MP; Pallini R; D'Alessandris QG; Levi A; Falchetti ML
    Expert Rev Mol Med; 2024 Apr; 26():e5. PubMed ID: 38563164
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Flotillin-1 is a prognostic biomarker for glioblastoma and promotes cancer development through enhancing invasion and altering tumour microenvironment.
    Wang R; Chen Z; Zhang Y; Xiao S; Zhang W; Hu X; Xiao Q; Liu Q; Wang X
    J Cell Mol Med; 2023 Feb; 27(3):392-402. PubMed ID: 36647700
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Comprehensive Analysis of the Prognostic Value and Molecular Function of CRNDE in Glioma at Bulk and Single-Cell Levels.
    Song L; Li X; Xu X; Huo X; Zheng Y; Wang X; Li D; Zhang J; Wang K; Wang L; Wu Z
    Cells; 2022 Nov; 11(22):. PubMed ID: 36429098
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. TNFα-induced idh1 hyperacetylation reprograms redox homeostasis and promotes the chemotherapeutic sensitivity.
    Yang H; Zhao X; Liu J; Jin M; Liu X; Yan J; Yao X; Mao X; Li N; Liang B; Xie W; Zhang K; Zhao J; Liu L; Huang G
    Oncogene; 2023 Jan; 42(1):35-48. PubMed ID: 36352097
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Identification and validation of a glycolysis-related gene signature for depicting clinical characteristics and its relationship with tumor immunity in patients with colon cancer.
    Liu G; Wu X; Chen J
    Aging (Albany NY); 2022 Aug; 14(21):8700-8718. PubMed ID: 35963622
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Deciphering the etiology and role in oncogenic transformation of the CpG island methylator phenotype: a pan-cancer analysis.
    Yates J; Boeva V
    Brief Bioinform; 2022 Mar; 23(2):. PubMed ID: 35134107
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Differential expression of the BCAT isoforms between breast cancer subtypes.
    Shafei MA; Flemban A; Daly C; Kendrick P; White P; Dean S; Qualtrough D; Conway ME
    Breast Cancer; 2021 May; 28(3):592-607. PubMed ID: 33367952
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. RIPK3 is a novel prognostic marker for lower grade glioma and further enriches idh mutational status subgrouping.
    Vergara GA; Eugenio GC; Malheiros SMF; Victor EDS; Weinlich R
    J Neurooncol; 2020 May; 147(3):587-594. PubMed ID: 32222932
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Assessment of Hepatic Arterial Infusion of Floxuridine in Combination With Systemic Gemcitabine and Oxaliplatin in Patients With Unresectable Intrahepatic Cholangiocarcinoma: A Phase 2 Clinical Trial.
    Cercek A; Boerner T; Tan BR; Chou JF; Gönen M; Boucher TM; Hauser HF; Do RKG; Lowery MA; Harding JJ; Varghese AM; Reidy-Lagunes D; Saltz L; Schultz N; Kingham TP; D'Angelica MI; DeMatteo RP; Drebin JA; Allen PJ; Balachandran VP; Lim KH; Sanchez-Vega F; Vachharajani N; Majella Doyle MB; Fields RC; Hawkins WG; Strasberg SM; Chapman WC; Diaz LA; Kemeny NE; Jarnagin WR
    JAMA Oncol; 2020 Jan; 6(1):60-67. PubMed ID: 31670750
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Exome sequencing of 22 genes using tissue from patients with biliary tract cancer.
    Høgdall D; Larsen OF; Linnemann D; Svenstrup Poulsen T; Høgdall EV
    APMIS; 2020 Jan; 128(1):3-9. PubMed ID: 31628675
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Targeted next-generation sequencing of well-differentiated rectal, gastric, and appendiceal neuroendocrine tumors to identify potential targets.
    Park HY; Kwon MJ; Kang HS; Kim YJ; Kim NY; Kim MJ; Min KW; Choi KC; Nam ES; Cho SJ; Park HR; Min SK; Seo J; Choe JY; Lee HK
    Hum Pathol; 2019 May; 87():83-94. PubMed ID: 30851333
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Correlation of idh1 and B7H3 expression with prognosis of CRC patients.
    Wu J; Wang F; Liu X; Zhang T; Liu F; Ge X; Mao Y; Hua D
    Eur J Surg Oncol; 2018 Aug; 44(8):1254-1260. PubMed ID: 29871819
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Mucinous intrahepatic cholangiocarcinoma: a distinct variant.
    Chi Z; Bhalla A; Saeed O; Cheng L; Curless K; Wang HL; Patil DT; Lin J
    Hum Pathol; 2018 Aug; 78():131-137. PubMed ID: 29698701
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Decreased expression of idh1-R132H correlates with poor survival in gastrointestinal cancer.
    Li J; Huang J; Huang F; Jin Q; Zhu H; Wang X; Chen M
    Oncotarget; 2016 Nov; 7(45):73638-73650. PubMed ID: 27655638
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. The Sensitive Detection of Telomerase Reverse Transcriptase Promoter Mutation by Amplification Refractory Mutation System-PCR.
    Liu J; Zhao Z; Sun M; Chen K; Yuan W; Jiang G
    Genet Test Mol Biomarkers; 2016 Feb; 20(2):90-3. PubMed ID: 26741813
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Mathematical analysis predicts imbalanced idh1/2 expression associates with 2-HG-inactivating β-oxygenation pathway in colorectal cancer.
    Koseki J; Colvin H; Fukusumi T; Nishida N; Konno M; Kawamoto K; Tsunekuni K; Matsui H; Doki Y; Mori M; Ishii H
    Int J Oncol; 2015 Mar; 46(3):1181-91. PubMed ID: 25586680
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Isocitrate dehydrogenase 1 R132C mutation occurs exclusively in microsatellite stable colorectal cancers with the CpG island methylator phenotype.
    Whitehall VL; Dumenil TD; McKeone DM; Bond CE; Bettington ML; Buttenshaw RL; Bowdler L; Montgomery GW; Wockner LF; Leggett BA
    Epigenetics; 2014 Nov; 9(11):1454-60. PubMed ID: 25496513
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. The CpG island methylator phenotype: what's in a name?
    Hughes LA; Melotte V; de Schrijver J; de Maat M; Smit VT; Bovée JV; French PJ; van den Brandt PA; Schouten LJ; de Meyer T; van Criekinge W; Ahuja N; Herman JG; Weijenberg MP; van Engeland M
    Cancer Res; 2013 Oct; 73(19):5858-68. PubMed ID: 23801749
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Immunohistochemical demonstration of isocitrate dehydrogenase 1 (idh1) mutation in a small subset of prostatic carcinomas.
    Mauzo SH; Lee M; Petros J; Hunter S; Chang CM; Shu HK; Bellail AC; Hao C; Cohen C
    Appl Immunohistochem Mol Morphol; 2014 Apr; 22(4):284-7. PubMed ID: 23235339
    [TBL] [Abstract] [Full Text] [Related]  

    of 1.